Clinical Trials Browser

Phase 3 × Breast Neoplasms × Radiation × Clear all

NCT02954874 2026-06-03

Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer

Phase 3 Active not recruiting

Breast Carcinoma In Situ, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00310180 2026-05-29

TAILORx

Phase 3 Active not recruiting

10,273 enrolled 14 charts

Breast Neoplasms

NCT03488693 2026-05-12

TAILOR RT

Phase 3 Recruiting

Breast Neoplasms

NCT04852887 2026-04-23

DEBRA

Phase 3 Recruiting

Breast Neoplasms

NCT00066690 2026-02-06

SOFT

Phase 3 Completed

3,066 enrolled 15 charts

Breast Neoplasms

NCT03324802 2024-05-02

Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery

Phase 3 Completed

107 enrolled 17 charts

Breast Neoplasms

NCT00805597 2016-08-08

Clinical Trial of Postmastectomy Radiotherapy in Breast Cancer With One to Three Positive Nodes

Phase 3 Terminated

Breast Neoplasms

NCT00016276 2013-01-16

Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer

Phase 3 Terminated

Breast Neoplasms, Inflammatory Breast Neoplasms, Cardiotoxicity